Interasma website

Content Manager Monday, 03 February 2014 12:11

After 10 years of growth and permanence in our old website, Interasma has created a new website accessing new technologies, with full integration to social media to provide more and better information to our members and to the medical community and patients interested in bronchial asthma globally.
Enjoy our renovated web site and new sections:

WCA 2014 - Program at a Glance

Juan Carlos Ivancevich Monday, 13 January 2014 15:35

The WCA-2014 Program at a Glance will be updated in due course. Please check back.

Saturday March 29
  Sunday March 30   Monday March 31   Tuesday April 1
    Morning Sessions   Morning Sessions   Morning Sessions
Morning Sessions   Morning Sessions   Morning Sessions   Morning Sessions
Break   Break   Break   Break
Key Note Lecture   Key Note Lecture   Key Note Lecture   Key Note Lecture
Lunch Symposia   Lunch Symposia   Lunch Symposia   Lunch Symposia
Plenary Session   Plenary Session   Plenary Session   Plenary Session
Break   Break   Break   Break
Afternoon Sessions   Afternoon Sessions   Afternoon Sessions   Afternoon Sessions
Opening Ceremony   Afternoon Sessions   Afternoon Sessions   Closing Ceremony
    Cultural Event   President's Dinner    


WCA 2014 - Scientific Board & Scientific Program Committee

Juan Carlos Ivancevich Wednesday, 08 January 2014 15:35
Scientific Advisory Board
Jean Bousquet, France
Andrea Rossi, Italy
Gustavo Rodrigo, Uruguay
Stephen T. Holgate, UK
Pediatric Advisory Board
Andy Bush, UK
Stanley Szefler, USA
Giovanni Rossi, Italy
Peter Le Souëf, Australia
Dirceu Solé, Brazil
Hugo Van Bever, Singapore
Karin Lødrup Carlsen, Norway
Adnan Čustović, UK.
Scientific Programme Committee
Carlos E. Baena-Cagnani, Argentina - G. Walter Canonica, Italy
Louis-Philippe Boulet, Canada - Lawrence DuBuske, USA
Mark FitzGerald, Canada
Gennaro D'Amato, Italy
Juan A. Mazzei, Argentina
Ruby Pawankar, Japan.
J. Christian Virchow, Germany
Interasma Project Leader
Niki Gargassoula, Greece email address: This email address is being protected from spambots. You need JavaScript enabled to view it.

WCA 2014 -Main Topics

Juan Carlos Ivancevich Tuesday, 07 January 2014 15:35
Track I: 
Adult: Knowledge Translating
.     Track II: 
Asthma Knowledge Translating
.     Track III: 
Paediatric Programme
  • Asthma: a disease of many phenotypes
  • Asthma in the elderly
  • Occupational asthma
  • Asthma and obesity: what is the relationship?
  • Biomarkers of treatment responses
  • Links between astma and rhinitis
  • Upper airway influences on lower airways
  • Basic principles of guidelines implementation
  • Translation of GINA strategy into care
  • How to address care gaps in primary care
  • Emergency approach to asthma attacks in adults
  • Management of asthma in pregnancy
  • Adherence to Treatment in Allergy, Asthma & COPD: a neglected issue.
  • COPD Treatments as future Asthma Treatment
  • Fixed airflow obstruction in Asthma: pathological basis and consequences for treatment
  • Inhaled corticosteroids: different mechanisms and efficacy in Asthma and COPD
  • LAMA in Asthma: only for patients with severe poorly reversible airflow obstruction?
  • Triple therapy (ICS + LABA + LAMA) popular in COPD but forbidden in Asthma?
  • Tobacco in asthma and rhinitis
  • Knowledge Translation in Health Care: from evidence to practice


  • Monoclonal antibodies
  • New COPD Treatments
  • PROTEOMICS: a step forward in understanding Asthma
  • Severe Asthma: a different phenotype or different phenotypes?
  • Genetic factors and epigenetics
  • How does epithelial integrity protect against environmental insults
  • Breakdown in epithelial protection in Rhinosinusitis
  • Role of component resolved diagnostics
  • Subphenotyping and endotyping asthma
  • Diagnostic genetic scores in personalising diagnoses of allergy and asthma
  • Pharmacogenetics in deciding treatment options
  • Biodiversity and allergic disease
  • What is climate change doing to our environment in relation to allergy trends?
  • The changing microbiome and allergy
  • Smoking Cessation – Essential part of asthma treatment
  • The role of infection in asthma exacerbations
  • New biologic agents for treating severe asthma
  • A Novel paradigm for generating relevant evidence for guidelines: real life trials
  • Clusters and biomarkers of severe asthma in adults
  • Allergens in acute asthma exacerbations


  • Chronic rhinosinusitis and asthma in childhood. How to deal with it?
  • Prenatal and early life gene/ environmental programming
  • Predictive risk of rhinitis for asthma in children
  • Allergic and non allergic rhinitis in children under 5: implications for care
  • Severe Paediatric asthma
  • Risk factors for wheezing/asthma in infants
  • Asthma and obesity: association or epiphenomenon
  • Pulmonary function in infants and its contribution for the diagnosis of asthma
  • Allergens and/or virus and/or allergens in the development of asthma: the chicken or the egg dilemma
  • Managing severe asthma in childhood
  • Lung function decline: when does it start?
  • Are COPD starting in infants?
  • The MEDALL project: mechanisms of allergy
  • PAPA: Prevention of Allergy, Prevention of Asthma
  • Measuring lung function in children
  • Inflammatory markers of asthma and children
  • Genome-wide association influencing allergic sensitization
  • The aerosol therapy and lung deposition in children
  • What is the role of bacteria in airway inflammation and wheezing?

XXII World Congress of Asthma - Scientific Programme Committee Message

Juan Carlos Ivancevich Monday, 06 January 2014 15:35

"Translating science into clinical practice: how to improve asthma management in 2014"

Significant achievements have been accomplished in the last few years in better understanding what asthma is, how it should be assessed in regard to control and severity and what its optimal therapy is. Unfortunately these improvements in our understanding of the disease have not always translated into better asthma management.
The 2014 World Congress on Asthma in Mexico City will review the key findings from recent research on both adult and paediatric asthma and how knowledge translation methods have evolved to better integrate research findings into care.
The origins and determinants of asthma, triggers and inducers, the new insight gained on the role of allergy, environmental and biodiversity changes, workplace hazards, respiratory infections and various aspects of assessment of the disease are among the topics that will be covered by world experts. The role of phenotyping/endotyping asthma, particularly when severe, and new therapeutic current and future advances will be covered.
A significant part of the meeting will be devoted to practical workshops on asthma testing and treatment delivery, as well as the integration of practice tools into day-to-day care. Sessions will discuss how to optimize the multidisciplinary approach to asthma management.
We and the members of the scientific and pediatric advisory board believe the impressive programme of WCA-2014 will be of interest to all those involved in research and care of asthma.


Lawrence DuBuske


Louis-Philippe Boulet


G. Walter Canonica


Carlos E. Baena-Cagnani

Lawrence DuBuske   Louis-Philippe Boulet   G. Walter Canonica   Carlos E. Baena-Cagnani

on behalf of the Scientific Programme Committee –WCA 2014 Mexico City INTERASMA

Interasma Board of Directors - Executive Committee

Juan Carlos Ivancevich Friday, 03 January 2014 15:35
INTERASMA Board of Directors
1st Vice-President
2nd Vice-President
3rd Vice-President
Past President
Secretary General
Carlos E. Baena-Cagnani, Argentina
G. Walter Canonica, Italy
Lawrence DuBuske, USA
Louis-Philippe Boulet, Canada
You-Young Kim, Korea
Carlos Nunes, Portugal
Ignacio J. Ansotegui, Spain
Ronald Dahl, Denmark
Members at Large
Alexandre Chuchalin, Russia
Alvaro Cruz, Brazil
Arzu Yorgancioglu, Turkey
Fulvio Braido, Italy

Jonathan Bernstein, USA
Ken Ohta, Japan
Osman Yusuf, Pakistan
Ralph Mösges, Germany
Ante Fink-Wagner, Germany
Juan Carlos Ivancevich, Argentina

XXII World Congress of Asthma

Content Manager Thursday, 02 January 2014 11:27

XXII World Congress of Asthma
March 29-April 1, 2014
Mexico DF, Mexico

We are very pleased to invite you to attend the XXII World Congress of Asthma in Mexico City 2014 (WCA-2014 Mexico). The WCA congresses have been organized by INTERASMA, the Global Asthma Association, since the first congress that took place in Lübeck in 1956. Many very succesfull congresses have been organised ever since, such as New Orleans, Lisbon, Paris, Maebashi, Monte Carlo, Jerusalem, Montpellier, Buenos Aires, Saint Petersbourg, Athens, and more recently the unforgettable WCA 2012 in Quebec, Canada, among others. In addition, many regional meetings were organized in Bilbao, Prague, Warsaw, Salsomaggiore, Palma de Gran Canaria, among others. The long life of INTERASMA has been related with excellent educational programmes about asthma and related conditions.

In 2014 INTERASMA is celebrating its 60th Anniversary as it was registered in 1954 in Milan, and we will celebrate it in México City during the XXII WCA Mexico City 2014. Mexico city is one of the most beautiful cities and one of the top five cultural destinations in the Americas. There are over 200 museums in Mexico City including one of the most remarkable anthropological museums in the World, the National Museum of Anthropology in which the most relevant and best-preserved pieces of the Maya and Aztec culture are exposed. The outstanding ancient city of Teotihuacan is also anthropologically significant for its complex, multi-family residential compounds and pyramids, and it is only a 45 minute drive away! Xochilmico, Frida Kahlo’s blue house in Coyohacan, and the gorgeous city of Mexico are additional attractions which make coming over to WCA 2014 Mexico city a unique experience, combined with the traditional Mexican culture (including the wonderful Mexican cuisine), its modern and lively daily life, a lovely, clean and safe city with unique Mexican hospitality.

Last but not least we are pleased to invite you to attend the WCA-2014 Mexico with the most comprehensive and excellent programme ever drawn by a group of asthma world-class experts.

Dear colleagues and friends, we will be delighted to welcome you in splendid Mexico City to celebrate the 60th Anniversary of INTERASMA!


Carlos Báez Loyola
Chair of the Local Organizing Committee

Carlos E. Baena-Cagnani
President of INTERASMA 2013-2014

Garo's test news item

Content Manager Friday, 12 July 2013 09:54


Interasma on Twitter

Interasma RT @Aller_MD: “VIDEO: #Dupilumab or cyclosporine for treating atopic dermatitis?”
Interasma RT @Aller_MD: “More than one in five infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital ad…
Interasma RT @Aller_MD: “FDA to Review BLA for Oral Immunotherapy AR101 for Peanut #Allergy
Interasma RT @Aller_MD: 10 startups tackling the problem of high prescription drug costs. Managing payments, connecting consumers to reimbursement op…
Interasma RT @Aller_MD: “Gastroesophageal reflux disease increases the risk of chronic rhinosinusitis”

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA